To explore cell-specific changes in gene expression across different α-synucleinopathies using single-nucleus RNA sequencing, aiming to enhance understanding of their molecular pathogenesis.
Key Findings:
Idiopathic PD and LRRK2-PD exhibit overlapping cell type-specific signatures distinct from MSA.
Overall decrease in transcriptional output in neurons observed in idiopathic PD and LRRK2-PD.
PDE10A consistently downregulated in most cortical neurons across all three disease groups.
Cell type-specific signatures associated with α-synuclein pathology identified, including neuronal upregulation of SNCA.
Interpretation:
The study provides insights into the transcriptional landscape of α-synucleinopathies, highlighting distinct molecular signatures and potential biomarkers for disease progression, which could inform future therapeutic strategies.
Limitations:
Study limited to the dorsolateral prefrontal cortex; findings may not generalize to other brain regions.
Sample size for some groups (e.g., MSA) is small, potentially affecting statistical power.
Potential biases in sample selection or analysis methods may influence results.
Conclusion:
Single-nucleus RNA sequencing reveals distinct molecular signatures in α-synucleinopathies, enhancing understanding of their pathogenesis and potential therapeutic targets.
by Gonzalo S Nido, Martina Castelli, Sepideh Mostafavi, Anna Rubiolo, Omnia Shadad, Guido Alves, Ole-Bjørn Tysnes, Irene H Flønes, Christian Dölle, Charalampos Tzoulis
